| abstract |
The present invention relates to the use of a compound having lysine-specific demethylase-1 inhibitory activity and useful for the treatment or prevention of diseases such as asthma, developmental disorders, particularly diseases accompanied by intellectual disability (for example, autism spectrum disorders, Rett syndrome, Down syndrome, Kabuki syndrome, Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, spinal cord cerebellar degeneration (for example, dysmenorrhea in the dentate nucleus) And Huntington ' s disease), epilepsy (e. G., Drebet syndrome) or drug dependency. A compound represented by the formula: Wherein each symbol is as defined herein. |